Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder

OBJECTIVE: This study examined the time course of efficacy‐related endpoints for lisdexamfetamine dimesylate (LDX) versus placebo in adults with protocol‐defined moderate to severe binge‐eating disorder (BED). METHODS: In two 12‐week, double‐blind, placebo‐controlled studies, adults meeting DSM‐IV‐T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Eat Disord
Autores principales: McElroy, Susan L., Hudson, James I., Gasior, Maria, Herman, Barry K., Radewonuk, Jana, Wilfley, Denise, Busner, Joan
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573905/
https://ncbi.nlm.nih.gov/pubmed/28481434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eat.22722
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares